Novo Holdings A/S - 08 Feb 2024 Form 3 Insider Report for Metagenomi Technologies, LLC (MGX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MGX	SERIES B PREFERRED STOCK							08 Feb 2024	COMMON STOCK	147,415		Direct	F1
holding	MGX	SERIES B-1 PREFERRED STOCK							08 Feb 2024	COMMON STOCK	691,760		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Each share of Series B Preferred Stock and Series B-1 Preferred Stock is convertible into Common Stock, on a one-for-one basis, automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. These shares have no expiration date.